| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 5.96e-07 | 3 | 169 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 6.04e-07 | 9 | 169 | 4 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 6.04e-07 | 9 | 169 | 4 | GO:0001640 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.37e-06 | 4 | 169 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 7.46e-05 | 27 | 169 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 4.23e-04 | 4 | 169 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 6.11e-04 | 20 | 169 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 6.11e-04 | 20 | 169 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.24e-04 | 81 | 169 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.44e-04 | 171 | 169 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication | 7.00e-04 | 5 | 169 | 2 | GO:0086083 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 1.04e-03 | 6 | 169 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.06e-03 | 24 | 169 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB6 VN1R4 GP6 ITGA11 NPY6R MFSD6 GRIK3 GRM4 GRM5 GRM6 ADGRG4 MET TAS2R14 NRXN3 IL1R2 PTPRZ1 EPHA2 GPR149 TLR3 SORCS2 HRH4 ADGRL2 IL6ST | 1.07e-03 | 1353 | 169 | 23 | GO:0004888 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 5.56e-07 | 9 | 171 | 4 | GO:0007196 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 7.68e-06 | 16 | 171 | 4 | GO:0007216 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 6.44e-05 | 10 | 171 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 6.44e-05 | 10 | 171 | 3 | GO:0009804 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.85e-05 | 109 | 176 | 7 | GO:0005796 | |
| Domain | EGF-like_CS | FAT4 MUC3B FAT3 LAMA1 ITGB4 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 EPHA2 VCAN MUC3A MUC4 | 1.70e-08 | 261 | 170 | 15 | IPR013032 |
| Domain | EGF_2 | FAT4 MUC3B FAT3 LAMA1 ITGB4 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 EPHA2 VCAN MUC3A MUC4 | 2.09e-08 | 265 | 170 | 15 | PS01186 |
| Domain | EGF_1 | FAT4 MUC3B FAT3 LAMA1 ITGB4 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 VCAN MUC3A MUC4 | 9.20e-08 | 255 | 170 | 14 | PS00022 |
| Domain | EGF | FAT4 MUC3B FAT3 LAMA1 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 VCAN MUC3A MUC4 | 2.47e-07 | 235 | 170 | 13 | SM00181 |
| Domain | EGF-like_dom | FAT4 MUC3B FAT3 LAMA1 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 VCAN MUC3A MUC4 | 4.79e-07 | 249 | 170 | 13 | IPR000742 |
| Domain | Alpha_tubulin | 8.06e-07 | 9 | 170 | 4 | IPR002452 | |
| Domain | EGF_3 | FAT4 MUC3B FAT3 LDLR HEG1 NRXN3 MALRD1 SCUBE2 MUC17 VCAN MUC3A MUC4 | 1.69e-06 | 235 | 170 | 12 | PS50026 |
| Domain | FN3 | MYBPH EPHB6 COL12A1 COL20A1 ITGB4 PTPRZ1 EPHA2 ATF7IP2 SDK1 HCFC1 IL6ST | 2.15e-06 | 199 | 170 | 11 | PS50853 |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 2.94e-06 | 4 | 170 | 3 | IPR008067 | |
| Domain | FN3_dom | MYBPH EPHB6 COL12A1 COL20A1 ITGB4 PTPRZ1 EPHA2 ATF7IP2 SDK1 HCFC1 IL6ST | 3.46e-06 | 209 | 170 | 11 | IPR003961 |
| Domain | SEA | 6.18e-06 | 14 | 170 | 4 | SM00200 | |
| Domain | Ig-like_fold | MYBPH EPHB6 GP6 CADM3 FLNB COL12A1 COL20A1 ITGB4 MET IGHA1 CD22 NEGR1 IL1R2 PTPRZ1 EPHA2 VCAN PKHD1 SDK1 HCFC1 IL6ST | 6.92e-06 | 706 | 170 | 20 | IPR013783 |
| Domain | FN3 | MYBPH EPHB6 COL12A1 COL20A1 ITGB4 PTPRZ1 EPHA2 SDK1 HCFC1 IL6ST | 7.70e-06 | 185 | 170 | 10 | SM00060 |
| Domain | - | MYBPH EPHB6 GP6 CADM3 FLNB COL12A1 COL20A1 ITGB4 MET CD22 NEGR1 IL1R2 PTPRZ1 EPHA2 VCAN PKHD1 SDK1 HCFC1 IL6ST | 1.02e-05 | 663 | 170 | 19 | 2.60.40.10 |
| Domain | Laminin_G | 1.42e-05 | 58 | 170 | 6 | IPR001791 | |
| Domain | fn3 | 1.78e-05 | 162 | 170 | 9 | PF00041 | |
| Domain | ANF_lig-bd_rcpt | 2.03e-05 | 37 | 170 | 5 | IPR001828 | |
| Domain | ANF_receptor | 2.03e-05 | 37 | 170 | 5 | PF01094 | |
| Domain | Peripla_BP_I | 2.64e-05 | 39 | 170 | 5 | IPR028082 | |
| Domain | ASX_HYDROXYL | 3.60e-05 | 100 | 170 | 7 | PS00010 | |
| Domain | GPCR_3_mtglu_rcpt | 4.01e-05 | 8 | 170 | 3 | IPR000162 | |
| Domain | Tubulin_C | 4.26e-05 | 22 | 170 | 4 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.26e-05 | 22 | 170 | 4 | IPR018316 | |
| Domain | Tubulin_C | 4.26e-05 | 22 | 170 | 4 | SM00865 | |
| Domain | Tub_FtsZ_C | 5.13e-05 | 23 | 170 | 4 | IPR008280 | |
| Domain | Tubulin_C | 5.13e-05 | 23 | 170 | 4 | IPR023123 | |
| Domain | TUBULIN | 5.13e-05 | 23 | 170 | 4 | PS00227 | |
| Domain | Tubulin | 5.13e-05 | 23 | 170 | 4 | IPR000217 | |
| Domain | Tubulin | 5.13e-05 | 23 | 170 | 4 | SM00864 | |
| Domain | SEA | 5.13e-05 | 23 | 170 | 4 | PS50024 | |
| Domain | SEA_dom | 5.13e-05 | 23 | 170 | 4 | IPR000082 | |
| Domain | Tubulin_CS | 5.13e-05 | 23 | 170 | 4 | IPR017975 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.23e-05 | 106 | 170 | 7 | IPR000152 | |
| Domain | Tubulin_FtsZ_GTPase | 6.11e-05 | 24 | 170 | 4 | IPR003008 | |
| Domain | Tubulin | 6.11e-05 | 24 | 170 | 4 | PF00091 | |
| Domain | ConA-like_dom | 1.84e-04 | 219 | 170 | 9 | IPR013320 | |
| Domain | NCD3G | 1.98e-04 | 13 | 170 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.98e-04 | 13 | 170 | 3 | IPR011500 | |
| Domain | - | 2.32e-04 | 95 | 170 | 6 | 2.60.120.200 | |
| Domain | Na/Pi_transpt | 2.46e-04 | 3 | 170 | 2 | IPR003841 | |
| Domain | Na_Pi_cotrans | 2.46e-04 | 3 | 170 | 2 | PF02690 | |
| Domain | GPCR_3_CS | 2.51e-04 | 14 | 170 | 3 | IPR017979 | |
| Domain | EGF_Ca-bd_CS | 2.60e-04 | 97 | 170 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.90e-04 | 99 | 170 | 6 | PS01187 | |
| Domain | LAM_G_DOMAIN | 3.84e-04 | 38 | 170 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 4.69e-04 | 40 | 170 | 4 | PF02210 | |
| Domain | Growth_fac_rcpt_ | 5.72e-04 | 156 | 170 | 7 | IPR009030 | |
| Domain | LamG | 6.77e-04 | 44 | 170 | 4 | SM00282 | |
| Domain | - | 7.54e-04 | 20 | 170 | 3 | 3.30.1330.20 | |
| Domain | - | 8.73e-04 | 21 | 170 | 3 | 1.10.287.600 | |
| Domain | GPCR_3 | 8.73e-04 | 21 | 170 | 3 | IPR000337 | |
| Domain | EGF_CA | 8.81e-04 | 122 | 170 | 6 | SM00179 | |
| Domain | VWFA | 9.13e-04 | 82 | 170 | 5 | PS50234 | |
| Domain | EGF-like_Ca-bd_dom | 9.59e-04 | 124 | 170 | 6 | IPR001881 | |
| Domain | 7tm_3 | 1.00e-03 | 22 | 170 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.00e-03 | 22 | 170 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.00e-03 | 22 | 170 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.00e-03 | 22 | 170 | 3 | PS00979 | |
| Domain | - | 1.00e-03 | 22 | 170 | 3 | 3.40.50.1440 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.00e-03 | 22 | 170 | 3 | PS50259 | |
| Domain | SEA | 1.00e-03 | 22 | 170 | 3 | PF01390 | |
| Domain | GPCR_3_C | 1.00e-03 | 22 | 170 | 3 | IPR017978 | |
| Domain | VWA | 1.02e-03 | 84 | 170 | 5 | SM00327 | |
| Domain | EGF | 1.04e-03 | 126 | 170 | 6 | PF00008 | |
| Domain | EGF_CA | 1.13e-03 | 86 | 170 | 5 | PF07645 | |
| Domain | - | 1.21e-03 | 6 | 170 | 2 | 3.90.1290.10 | |
| Domain | Kinesin-like | 1.21e-03 | 6 | 170 | 2 | IPR022164 | |
| Domain | DUF3694 | 1.21e-03 | 6 | 170 | 2 | PF12473 | |
| Domain | Ephrin_rec_like | 1.47e-03 | 25 | 170 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.47e-03 | 25 | 170 | 3 | IPR011641 | |
| Domain | Plectin | 1.68e-03 | 7 | 170 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.68e-03 | 7 | 170 | 2 | IPR001101 | |
| Domain | PLEC | 1.68e-03 | 7 | 170 | 2 | SM00250 | |
| Domain | VWA | 1.68e-03 | 56 | 170 | 4 | PF00092 | |
| Domain | VWF_A | 2.12e-03 | 99 | 170 | 5 | IPR002035 | |
| Domain | PH-BEACH_dom | 2.22e-03 | 8 | 170 | 2 | IPR023362 | |
| Domain | - | 2.22e-03 | 8 | 170 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.22e-03 | 8 | 170 | 2 | PS51783 | |
| Domain | BEACH | 2.84e-03 | 9 | 170 | 2 | PS50197 | |
| Domain | Beach | 2.84e-03 | 9 | 170 | 2 | PF02138 | |
| Domain | - | 2.84e-03 | 9 | 170 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.84e-03 | 9 | 170 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.84e-03 | 9 | 170 | 2 | IPR000409 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.68e-07 | 16 | 132 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.77e-07 | 17 | 132 | 5 | M27412 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.96e-06 | 23 | 132 | 5 | M19135 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.96e-06 | 23 | 132 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.75e-06 | 26 | 132 | 5 | M27483 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.59e-05 | 17 | 132 | 4 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.59e-05 | 17 | 132 | 4 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.03e-05 | 18 | 132 | 4 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.55e-05 | 19 | 132 | 4 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.55e-05 | 19 | 132 | 4 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 3.17e-05 | 20 | 132 | 4 | M47890 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 3.17e-05 | 20 | 132 | 4 | MM1383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 3.17e-05 | 20 | 132 | 4 | M47911 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.88e-05 | 21 | 132 | 4 | MM15706 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.88e-05 | 21 | 132 | 4 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.88e-05 | 21 | 132 | 4 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 4.71e-05 | 22 | 132 | 4 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 5.67e-05 | 23 | 132 | 4 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 5.67e-05 | 23 | 132 | 4 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 6.75e-05 | 24 | 132 | 4 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.75e-05 | 24 | 132 | 4 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.98e-05 | 25 | 132 | 4 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.98e-05 | 25 | 132 | 4 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 9.36e-05 | 26 | 132 | 4 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.36e-05 | 26 | 132 | 4 | M47672 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.09e-04 | 27 | 132 | 4 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.09e-04 | 27 | 132 | 4 | MM15674 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.25e-04 | 11 | 132 | 3 | M27130 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.26e-04 | 28 | 132 | 4 | M47898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.45e-04 | 29 | 132 | 4 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.45e-04 | 29 | 132 | 4 | M27948 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.66e-04 | 12 | 132 | 3 | MM14847 | |
| Pathway | REACTOME_KINESINS | 1.89e-04 | 57 | 132 | 5 | MM15714 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.16e-04 | 32 | 132 | 4 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.16e-04 | 32 | 132 | 4 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.16e-04 | 32 | 132 | 4 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.43e-04 | 33 | 132 | 4 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.43e-04 | 33 | 132 | 4 | M47901 | |
| Pathway | REACTOME_KINESINS | 2.61e-04 | 61 | 132 | 5 | M977 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.81e-04 | 62 | 132 | 5 | M546 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.07e-04 | 35 | 132 | 4 | M47774 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.36e-04 | 15 | 132 | 3 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.36e-04 | 15 | 132 | 3 | MM15845 | |
| Pathway | REACTOME_AGGREPHAGY | 3.43e-04 | 36 | 132 | 4 | MM15669 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.82e-04 | 37 | 132 | 4 | MM15067 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.82e-04 | 37 | 132 | 4 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.24e-04 | 38 | 132 | 4 | M14981 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.34e-04 | 68 | 132 | 5 | M27303 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.69e-04 | 39 | 132 | 4 | M793 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.91e-04 | 18 | 132 | 3 | MM14841 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.83e-04 | 43 | 132 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 6.83e-04 | 43 | 132 | 4 | M47773 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 7.46e-04 | 44 | 132 | 4 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 7.46e-04 | 44 | 132 | 4 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.46e-04 | 44 | 132 | 4 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 8.13e-04 | 45 | 132 | 4 | M47670 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 8.54e-04 | 5 | 132 | 2 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 8.54e-04 | 5 | 132 | 2 | MM15085 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 8.54e-04 | 5 | 132 | 2 | M47808 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 8.84e-04 | 46 | 132 | 4 | M27828 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.04e-03 | 48 | 132 | 4 | MM15353 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.12e-03 | 49 | 132 | 4 | M891 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.23e-03 | 127 | 132 | 6 | M27181 | |
| Pathway | REACTOME_XENOBIOTICS | 1.24e-03 | 23 | 132 | 3 | M5372 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.31e-03 | 51 | 132 | 4 | M26972 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.34e-03 | 129 | 132 | 6 | MM14894 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.40e-03 | 52 | 132 | 4 | MM14949 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.51e-03 | 53 | 132 | 4 | M27651 | |
| Pathway | KEGG_GAP_JUNCTION | 1.55e-03 | 90 | 132 | 5 | M4013 | |
| Pathway | REACTOME_XENOBIOTICS | 1.59e-03 | 25 | 132 | 3 | MM14846 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | KCNH8 TUBA1C GRIK3 TUBA8 GRM5 TUBA4A SLC6A3 TUBA1B NRXN3 KCNQ4 EPB41L2 | 1.66e-03 | 411 | 132 | 11 | M735 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.73e-03 | 55 | 132 | 4 | M39613 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 1.78e-03 | 26 | 132 | 3 | M47923 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.85e-03 | 56 | 132 | 4 | M2333 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.88e-03 | 94 | 132 | 5 | MM14515 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.98e-03 | 57 | 132 | 4 | M27251 | |
| Pathway | WP_NRF2_PATHWAY | 2.10e-03 | 141 | 132 | 6 | M39454 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.26e-03 | 143 | 132 | 6 | M27275 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.26e-03 | 98 | 132 | 5 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.26e-03 | 98 | 132 | 5 | M776 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.39e-03 | 60 | 132 | 4 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.44e-03 | 250 | 132 | 8 | M27554 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.47e-03 | 100 | 132 | 5 | M27650 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.69e-03 | 62 | 132 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.02e-03 | 64 | 132 | 4 | M5650 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.18e-03 | 106 | 132 | 5 | M27200 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.26e-03 | 32 | 132 | 3 | MM15326 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.38e-03 | 66 | 132 | 4 | MM17074 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.38e-03 | 66 | 132 | 4 | MM15925 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.44e-03 | 108 | 132 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.58e-03 | 109 | 132 | 5 | MM15074 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 3.77e-03 | 68 | 132 | 4 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.77e-03 | 68 | 132 | 4 | MM14968 | |
| Pubmed | VPS18 KIF1A PIGS ATG2B POR RABGAP1 LYST WASHC5 ANO6 EPHA2 SYNE2 PLEKHM3 ADGRL2 FAM135A MTDH RIC1 MAD2L1 | 1.14e-09 | 504 | 178 | 17 | 34432599 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.69e-08 | 18 | 178 | 5 | 18834073 | |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 4.57e-08 | 8 | 178 | 4 | 16148047 | |
| Pubmed | PMS1 CASP8AP2 GRWD1 DSC2 RPN2 TUBA1C UBR4 MRPL53 KIAA1549 POR EXOSC8 DDB1 LRRC47 TBC1D8 MET IARS2 THADA ANO6 EPHA2 SYNE2 ADGRL2 DNAJB2 FAM135A MTDH EPB41L2 RAD21 | 4.64e-08 | 1487 | 178 | 26 | 33957083 | |
| Pubmed | 8.19e-08 | 9 | 178 | 4 | 21167302 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 8.19e-08 | 9 | 178 | 4 | 11953448 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 20840855 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8188299 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8250953 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 2703500 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 22217847 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 2733794 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8484736 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 24045421 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 2765478 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 2415518 | ||
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 1.32e-07 | 3 | 178 | 3 | 31645370 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 8297477 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 10512748 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 1.32e-07 | 3 | 178 | 3 | 22890016 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 3346244 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 1417950 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 32987105 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB EPPK1 DIABLO DSP RPN2 UBR4 RNF213 EXOSC8 MUC5B RABGAP1 WNK1 DDB1 LRRC47 TBCB IARS2 IGHA1 WASHC5 ANO6 EPHA2 SYNE2 DNAJB2 HCFC1 MAD2L1 RAD21 | 1.50e-07 | 1367 | 178 | 24 | 32687490 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 ITGA11 HTRA1 COL12A1 MAN2B1 RPN2 PIGS LAMA1 KIAA1549 RNF213 RABGAP1 DDB1 ITGB4 LDLR MET THADA HEG1 NEGR1 ANO6 EPHA2 MTDH IL6ST | 2.53e-07 | 1201 | 178 | 22 | 35696571 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB FAT4 CCDC73 KIF1A DSP TOPAZ1 UBR4 LAMA1 INTS1 RNF213 C11orf24 ICE1 TMEM132B LRRC47 TLR3 PKHD1 EPB41L2 | 2.78e-07 | 736 | 178 | 17 | 29676528 |
| Pubmed | FLNB EPPK1 KIF1A DSP RPN2 TUBA1C UBR4 INTS1 DDB1 LRRC47 IARS2 SYNE2 KMT2A HCFC1 EPB41L2 RAD21 | 2.90e-07 | 653 | 178 | 16 | 22586326 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 3.18e-07 | 12 | 178 | 4 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 4.57e-07 | 13 | 178 | 4 | 10908577 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 5.25e-07 | 4 | 178 | 3 | 1970547 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 9408084 | ||
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 7565685 | ||
| Pubmed | 6.38e-07 | 14 | 178 | 4 | 12486001 | ||
| Pubmed | FLNB VPS18 HTRA1 NAT9 DSP TUBA1C KIAA1549 POR GRM5 DDB1 TUBA4A OPHN1 LRRC47 WASHC5 NEGR1 SLC24A2 PTPRZ1 VCAN SORCS2 KMT2A PCDH1 MTDH EPB41L2 | 1.27e-06 | 1431 | 178 | 23 | 37142655 | |
| Pubmed | Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody. | 1.31e-06 | 5 | 178 | 3 | 6984010 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.39e-06 | 208 | 178 | 9 | 33230847 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EPHB6 KIF1A LUC7L3 TOPAZ1 MUC16 GRM4 CDC14A EPHA2 GPR149 ATF7IP2 UNC80 EPB41L2 | 1.96e-06 | 420 | 178 | 12 | 28065597 |
| Pubmed | 2.42e-06 | 19 | 178 | 4 | 15698476 | ||
| Pubmed | 2.42e-06 | 19 | 178 | 4 | 15691386 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 7668294 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 18613978 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 8587134 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 3785200 | ||
| Pubmed | The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. | 2.61e-06 | 6 | 178 | 3 | 11943148 | |
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 2.61e-06 | 6 | 178 | 3 | 7651436 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 16327313 | ||
| Pubmed | FAT4 DSC2 TUBA1C POR MUC16 RNF213 MET IARS2 THADA ANO6 EPHA2 ADGRL2 FAM135A SDK1 MTDH EPB41L2 | 2.79e-06 | 777 | 178 | 16 | 35844135 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.77e-06 | 235 | 178 | 9 | 30258100 | |
| Pubmed | 3.84e-06 | 46 | 178 | 5 | 19190083 | ||
| Pubmed | 4.51e-06 | 22 | 178 | 4 | 28117675 | ||
| Pubmed | 4.51e-06 | 22 | 178 | 4 | 15103018 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 9630227 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 36681692 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 14630516 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 9920659 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 11146551 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 6.51e-06 | 24 | 178 | 4 | 35746896 | |
| Pubmed | PMS1 RC3H2 MAN2B1 LUC7L3 RPN2 CWC22 TUBA4A SMYD4 TMEM62 ARAP3 WASHC5 KMT2A HCFC1 RIC1 | 7.23e-06 | 650 | 178 | 14 | 38777146 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.53e-06 | 256 | 178 | 9 | 33397691 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 3917435 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 37838304 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB EPPK1 GRWD1 LUC7L3 DSP RPN2 TUBA1C UBR4 WNK1 DDB1 LDLR TUBA4A LRRC47 TUBA1B GCLM SYNE2 MTDH HCFC1 EPB41L2 VCPIP1 RAD21 | 1.28e-05 | 1415 | 178 | 21 | 28515276 |
| Pubmed | 1.40e-05 | 101 | 178 | 6 | 10997877 | ||
| Pubmed | 1.40e-05 | 101 | 178 | 6 | 18519826 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB GRWD1 KIF1A LUC7L3 DIABLO DSP RPN2 TUBA1C UBR4 POR CWC22 DDB1 LRRC47 TUBA1B IARS2 THADA MTDH HCFC1 EPB41L2 MGAM2 RAD21 | 1.42e-05 | 1425 | 178 | 21 | 30948266 |
| Pubmed | 1.48e-05 | 153 | 178 | 7 | 10718198 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 1.54e-05 | 10 | 178 | 3 | 9069281 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 MAN2B1 TSNARE1 UBR4 INTS1 EXOSC8 ICE1 WNK1 LYST ITGB4 LDLR THADA HEG1 C2CD3 ARAP3 DEPDC5 HCFC1 RIC1 | 1.64e-05 | 1105 | 178 | 18 | 35748872 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.85e-05 | 219 | 178 | 8 | 31353912 | |
| Pubmed | FLNB DSC2 DSP RPN2 ATG2B DDB1 TBC1D8 GCLM EPHA2 ADGRL2 FAM135A HCFC1 EPB41L2 VCPIP1 | 1.87e-05 | 708 | 178 | 14 | 39231216 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 30489008 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 12325023 | ||
| Pubmed | Evidence for multiple, developmentally regulated isoforms of Ptprq on hair cells of the inner ear. | 2.60e-05 | 2 | 178 | 2 | 20715155 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 26719224 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 30876690 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 1302041 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 1520280 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 23917075 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25239188 | ||
| Pubmed | Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma. | 2.60e-05 | 2 | 178 | 2 | 23812675 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 2.60e-05 | 2 | 178 | 2 | 10973822 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 30154104 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21418183 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 28234895 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17574207 | ||
| Pubmed | Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate. | 2.60e-05 | 2 | 178 | 2 | 17310099 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 14690056 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 22986785 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24768041 | ||
| Pubmed | Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. | 2.60e-05 | 2 | 178 | 2 | 15175354 | |
| Pubmed | Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. | 2.60e-05 | 2 | 178 | 2 | 29328911 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 35816432 | ||
| Pubmed | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 2.60e-05 | 2 | 178 | 2 | 22696418 | |
| Pubmed | MACC1 is related to colorectal cancer initiation and early-stage invasive growth. | 2.60e-05 | 2 | 178 | 2 | 24124150 | |
| Pubmed | MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. | 2.60e-05 | 2 | 178 | 2 | 22179665 | |
| Pubmed | Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | 2.60e-05 | 2 | 178 | 2 | 30222954 | |
| Pubmed | Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. | 2.60e-05 | 2 | 178 | 2 | 22493396 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25526961 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 18818413 | ||
| Interaction | CYP2A7 interactions | 6.22e-07 | 3 | 173 | 3 | int:CYP2A7 | |
| Interaction | GRM7 interactions | 1.84e-05 | 19 | 173 | 4 | int:GRM7 | |
| Interaction | KCNA3 interactions | FLNB EPPK1 DSC2 CCDC73 DSP RPN2 LAMA1 ATG2B RNF213 DDB1 TBC1D8 GCLM EPHA2 TLR3 PKHD1 KMT2A ADGRL2 FAM135A HCFC1 EPB41L2 VCPIP1 | 1.93e-05 | 871 | 173 | 21 | int:KCNA3 |
| Interaction | TCP11L2 interactions | 2.80e-05 | 21 | 173 | 4 | int:TCP11L2 | |
| Interaction | RNF123 interactions | PMS1 FLNB FAT4 CCDC73 KIF1A DSP TOPAZ1 UBR4 LAMA1 INTS1 RNF213 C11orf24 ICE1 TMEM132B LRRC47 TLR3 PKHD1 MTDH EPB41L2 RAD21 | 2.82e-05 | 824 | 173 | 20 | int:RNF123 |
| Interaction | LGALS1 interactions | MYCN FAT4 FAT3 KIAA1549 MUC16 LDLR MET HEG1 PTPRZ1 VCAN SDK1 IL6ST | 3.12e-05 | 332 | 173 | 12 | int:LGALS1 |
| Cytoband | 15q14-q15 | 1.48e-04 | 5 | 178 | 2 | 15q14-q15 | |
| GeneFamily | CD molecules|Mucins | 4.82e-09 | 21 | 125 | 6 | 648 | |
| GeneFamily | Fibronectin type III domain containing | MYBPH EPHB6 COL12A1 COL20A1 ITGB4 PTPRZ1 EPHA2 PTPRQ ATF7IP2 SDK1 IL6ST | 1.44e-08 | 160 | 125 | 11 | 555 |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.76e-05 | 8 | 125 | 3 | 281 | |
| GeneFamily | Tubulins | 2.89e-05 | 26 | 125 | 4 | 778 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.29e-03 | 8 | 125 | 2 | 939 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.65e-03 | 9 | 125 | 2 | 1230 | |
| GeneFamily | Cytochrome P450 family 2 | 1.80e-03 | 35 | 125 | 3 | 1001 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL12A1 FAT3 LAMA1 MUC5B GRIK3 SLC24A2 GUCY2F ASXL3 PTPRQ PKHD1 SDK1 UNC80 | 5.57e-13 | 184 | 177 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL12A1 FAT3 LAMA1 MUC5B GRIK3 SLC24A2 GUCY2F ASXL3 PTPRQ PKHD1 SDK1 UNC80 | 5.57e-13 | 184 | 177 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 COL12A1 FAT3 LAMA1 MUC5B GRIK3 SLC24A2 GUCY2F ASXL3 PTPRQ PKHD1 SDK1 UNC80 | 5.57e-13 | 184 | 177 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | CYP2A13 CLCA4 DSP MUC16 MUC5B ITGB4 FER1L6 MET PTPRZ1 MUC4 SDK1 SLC6A14 | 2.40e-11 | 196 | 177 | 12 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CYP2A7 CYP2A13 HTRA1 FAT3 BEST3 MUC5B FSIP2 MET SCUBE2 PTPRZ1 SDK1 | 7.10e-11 | 166 | 177 | 11 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CYP2A7 CYP2A13 HTRA1 FAT3 BEST3 MUC5B FSIP2 MET SCUBE2 PTPRZ1 SDK1 | 7.10e-11 | 166 | 177 | 11 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CYP2A7 CYP2A13 HTRA1 FAT3 BEST3 MUC5B FSIP2 MET SCUBE2 PTPRZ1 SDK1 | 7.10e-11 | 166 | 177 | 11 | 4586d6725403f879fc96f67be579022587ce1906 |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | FLNB CYP2A13 GLIS3 MUC16 MUC5B FER1L6 MET NRXN3 PTPRZ1 MUC4 SDK1 | 1.91e-10 | 182 | 177 | 11 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MACC1 GLIS3 MUC16 FER1L6 MET MCTP1 PTPRZ1 FAM83D MUC4 SDK1 SLC6A14 | 4.20e-10 | 196 | 177 | 11 | b07db4a53ab9be9aad6fae5e45f9547db829d096 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FLNB FAT4 COL12A1 RNF213 HEG1 ARAP3 MCTP1 SYNE2 KMT2A ADGRL2 FAM135A | 5.21e-10 | 200 | 177 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.70e-09 | 170 | 177 | 10 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | FLNB CYP2A13 MUC16 MUC5B FER1L6 NRXN3 PTPRZ1 FAM83D MUC4 SDK1 | 2.01e-09 | 173 | 177 | 10 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | KCNH8 MUC16 MUC5B ITGB4 FER1L6 SULT1C2 MUC17 MUC3A MUC4 MGAM2 | 3.46e-09 | 183 | 177 | 10 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.72e-09 | 189 | 177 | 10 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CADM3 HTRA1 COL20A1 BEST3 TUBA8 GRM5 TMEM132B OPHN1 PTPRZ1 VCAN | 4.96e-09 | 190 | 177 | 10 | 6c7e1086c0a274cd5527c3104106e372811c9905 |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.96e-09 | 190 | 177 | 10 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.77e-09 | 193 | 177 | 10 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.36e-09 | 195 | 177 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.36e-09 | 195 | 177 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MACC1 CLCA4 DSP MUC16 MUC5B FER1L6 EPHA2 FAM83D MUC4 SLC6A14 | 6.68e-09 | 196 | 177 | 10 | a52879a4c822c5e4be569f01f845a795e00c5f4b |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.68e-09 | 196 | 177 | 10 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MACC1 CLCA4 DSP MUC16 MUC5B FER1L6 EPHA2 FAM83D MUC4 SLC6A14 | 6.68e-09 | 196 | 177 | 10 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.02e-09 | 197 | 177 | 10 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.37e-09 | 198 | 177 | 10 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CYP2A6 CYP2A7 CYP2A13 DSP MUC5B FER1L6 MET SCUBE2 PTPRZ1 MUC4 | 7.73e-09 | 199 | 177 | 10 | 2b17694cffbec28a2c8f165dfcff6bab94aa0f4c |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CYP2A13 MUC16 SLC34A2 MUC5B FER1L6 MET PTPRZ1 FAM83D MUC4 SLC6A14 | 7.73e-09 | 199 | 177 | 10 | 70c0b9cff195d3d24e98443a729e211cac20c90f |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Club|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | CYP2A6 CYP2A7 CYP2A13 DSP MUC5B FER1L6 MET SCUBE2 PTPRZ1 MUC4 | 7.73e-09 | 199 | 177 | 10 | 111cfd589ec6795075d8d88d7664bfb23eba5bf6 |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CYP2A6 CYP2A7 CYP2A13 DSP MUC5B FER1L6 MET SCUBE2 PTPRZ1 MUC4 | 7.73e-09 | 199 | 177 | 10 | d583290a1d288b749ad17bc501c1487268c6551c |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.11e-09 | 200 | 177 | 10 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-08 | 160 | 177 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-08 | 160 | 177 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-08 | 161 | 177 | 9 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.18e-08 | 165 | 177 | 9 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-08 | 168 | 177 | 9 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.54e-08 | 168 | 177 | 9 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.68e-08 | 169 | 177 | 9 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-08 | 173 | 177 | 9 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.44e-08 | 174 | 177 | 9 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-08 | 174 | 177 | 9 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-08 | 179 | 177 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 4.40e-08 | 179 | 177 | 9 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-08 | 180 | 177 | 9 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-08 | 180 | 177 | 9 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 4.61e-08 | 180 | 177 | 9 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.84e-08 | 181 | 177 | 9 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.57e-08 | 184 | 177 | 9 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-08 | 185 | 177 | 9 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 6.11e-08 | 186 | 177 | 9 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-08 | 189 | 177 | 9 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 8.02e-08 | 192 | 177 | 9 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 8.39e-08 | 193 | 177 | 9 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.39e-08 | 193 | 177 | 9 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.39e-08 | 193 | 177 | 9 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-08 | 194 | 177 | 9 | 8c6e5ba27a988e0cd6b8c25cb9a30a0da2b1f7f9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-08 | 194 | 177 | 9 | 5b29c843186c2394f5bec3b1d5ae284a0d931d85 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-08 | 194 | 177 | 9 | ebcf6c6d0eb20a5d422becf5a730089230c8ba9a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-08 | 194 | 177 | 9 | 6e78e3046c5b172af92a84e25f982377a0aaac58 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.16e-08 | 195 | 177 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.57e-08 | 196 | 177 | 9 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.57e-08 | 196 | 177 | 9 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.57e-08 | 196 | 177 | 9 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.57e-08 | 196 | 177 | 9 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.99e-08 | 197 | 177 | 9 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.99e-08 | 197 | 177 | 9 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.99e-08 | 197 | 177 | 9 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.99e-08 | 197 | 177 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.99e-08 | 197 | 177 | 9 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-07 | 198 | 177 | 9 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-07 | 199 | 177 | 9 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.09e-07 | 199 | 177 | 9 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-07 | 199 | 177 | 9 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 199 | 177 | 9 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 1.14e-07 | 200 | 177 | 9 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 200 | 177 | 9 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.14e-07 | 200 | 177 | 9 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.14e-07 | 200 | 177 | 9 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.75e-07 | 161 | 177 | 8 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-07 | 162 | 177 | 8 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-07 | 162 | 177 | 8 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-07 | 162 | 177 | 8 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-07 | 162 | 177 | 8 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 3.81e-07 | 168 | 177 | 8 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 4.76e-07 | 173 | 177 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.97e-07 | 174 | 177 | 8 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.42e-07 | 176 | 177 | 8 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-07 | 177 | 177 | 8 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-07 | 177 | 177 | 8 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-07 | 178 | 177 | 8 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.91e-07 | 178 | 177 | 8 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-07 | 178 | 177 | 8 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.91e-07 | 178 | 177 | 8 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.91e-07 | 178 | 177 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.16e-07 | 179 | 177 | 8 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-07 | 180 | 177 | 8 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.43e-07 | 180 | 177 | 8 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-07 | 180 | 177 | 8 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 6.70e-07 | 181 | 177 | 8 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 181 | 177 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 181 | 177 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 181 | 177 | 8 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| Drug | 2'-methoxyacetophenone | 4.62e-07 | 3 | 177 | 3 | CID000068481 | |
| Drug | Epothilone D | 1.66e-06 | 12 | 177 | 4 | DB01873 | |
| Drug | Epothilone B | 1.66e-06 | 12 | 177 | 4 | DB03010 | |
| Drug | taxol | CYP2A6 CYP2A7 MACC1 CYP2A13 HTRA1 KIF1A DIABLO TUBA1C LAMA1 TUBA8 ITGB4 TUBA4A TUBA1B TAF4 DNAJB2 IL6ST MAD2L1 | 1.91e-06 | 560 | 177 | 17 | CID000004666 |
| Drug | AC1L1DME | 1.94e-06 | 75 | 177 | 7 | CID000002414 | |
| Drug | N-nitrosomethylaniline | 3.33e-06 | 14 | 177 | 4 | CID000011957 | |
| Drug | 2-demethylcolchicine | 4.56e-06 | 32 | 177 | 5 | CID000023757 | |
| Drug | 3HPG | 7.76e-06 | 17 | 177 | 4 | CID000001217 | |
| Drug | AC1MBZ3L | 9.08e-06 | 6 | 177 | 3 | CID002733524 | |
| Drug | benzyloxyaspartate | 9.56e-06 | 37 | 177 | 5 | CID004133412 | |
| Drug | acromelic acid A | 9.92e-06 | 18 | 177 | 4 | CID000108086 | |
| Drug | L-BMAA | 1.09e-05 | 38 | 177 | 5 | CID000028558 | |
| Drug | CGS 19755 | 1.09e-05 | 38 | 177 | 5 | CID000068736 | |
| Drug | DETC-MeSO | 1.25e-05 | 39 | 177 | 5 | CID003035711 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 1.55e-05 | 20 | 177 | 4 | CID000001297 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.57e-05 | 186 | 177 | 9 | 4463_UP | |
| Drug | cyclothiazide | 1.61e-05 | 103 | 177 | 7 | CID000002910 | |
| Drug | LY341495 | 2.03e-05 | 43 | 177 | 5 | CID006324636 | |
| Drug | Joro spider toxin | 2.03e-05 | 43 | 177 | 5 | CID000119582 | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 3862_UP | |
| Drug | cis-MCG-I | 2.51e-05 | 8 | 177 | 3 | CID003035584 | |
| Drug | 2-amino-3-phosphonopropionic acid | 2.82e-05 | 76 | 177 | 6 | CID000003857 | |
| Drug | Docetaxel trihydrate | 3.02e-05 | 202 | 177 | 9 | CID000003143 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 3.32e-05 | 24 | 177 | 4 | CID003645780 | |
| Drug | phorbol 12,13-diacetate | 3.50e-05 | 48 | 177 | 5 | CID000072293 | |
| Drug | N-nitrosoguvacoline | 3.75e-05 | 9 | 177 | 3 | CID000062103 | |
| Drug | 3-(methylnitrosamino)propionaldehyde | 3.75e-05 | 9 | 177 | 3 | CID000098533 | |
| Drug | mM PEP | 3.75e-05 | 9 | 177 | 3 | CID005311462 | |
| Drug | AC1N21PP | 3.75e-05 | 9 | 177 | 3 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 3.75e-05 | 9 | 177 | 3 | CID000107216 | |
| Drug | methylenecyclopropylglycine | 3.88e-05 | 49 | 177 | 5 | CID000441452 | |
| Drug | AC1NB8R3 | 4.57e-05 | 213 | 177 | 9 | CID004489307 | |
| Drug | AC1NQH9B | 4.62e-05 | 26 | 177 | 4 | CID005221504 | |
| Drug | LY354740 | 4.72e-05 | 51 | 177 | 5 | CID000114827 | |
| Drug | TK-B | 4.72e-05 | 51 | 177 | 5 | CID000009074 | |
| Drug | AC1L1EKQ | 5.19e-05 | 52 | 177 | 5 | CID000002834 | |
| Drug | NS-105 | 5.33e-05 | 10 | 177 | 3 | CID000198695 | |
| Drug | monacolin X | 6.01e-05 | 2 | 177 | 2 | CID000125978 | |
| Drug | propargyl ether | 6.01e-05 | 2 | 177 | 2 | ctd:C531209 | |
| Drug | 1-benzyl-apdc | 6.01e-05 | 2 | 177 | 2 | CID005310978 | |
| Drug | Hempa | 6.01e-05 | 2 | 177 | 2 | ctd:D006492 | |
| Drug | nicotine imine | 6.01e-05 | 2 | 177 | 2 | ctd:C034629 | |
| Drug | alpha-nicotyrine | 6.01e-05 | 2 | 177 | 2 | ctd:C008615 | |
| Drug | N-nitrosoguvacoline | 6.01e-05 | 2 | 177 | 2 | ctd:C036676 | |
| Drug | benomyl | 6.53e-05 | 128 | 177 | 7 | CID000028780 | |
| Drug | AC1NUW3V | 7.20e-05 | 29 | 177 | 4 | CID005462126 | |
| Drug | oxibendazole | 7.20e-05 | 29 | 177 | 4 | CID000004622 | |
| Drug | Aids106696 | 7.20e-05 | 29 | 177 | 4 | CID006475933 | |
| Drug | cyclobutylene AP5 | 7.28e-05 | 11 | 177 | 3 | CID000126582 | |
| Drug | quinolinic acid | 8.22e-05 | 179 | 177 | 8 | CID000001066 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 8.26e-05 | 30 | 177 | 4 | CID000001226 | |
| Drug | L-quisqualic acid | 8.54e-05 | 180 | 177 | 8 | CID000001209 | |
| Drug | trans-3,4,5-trihydroxystilbene | DSC2 DIABLO TUBA1C GRIK3 GRINA TUBA8 GRM4 GRM5 GRM6 LYST CDC14A TUBA4A GCLM GUCY2F MAD2L1 | 8.58e-05 | 608 | 177 | 15 | CID000005056 |
| Drug | GYKI 52466 | 8.81e-05 | 58 | 177 | 5 | CID000003538 | |
| Drug | AC1L3V8I | 9.43e-05 | 31 | 177 | 4 | CID000122777 | |
| Drug | MPEP | 9.56e-05 | 59 | 177 | 5 | CID003025961 | |
| Drug | AL-20 | 9.65e-05 | 12 | 177 | 3 | CID000002782 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 1.07e-04 | 32 | 177 | 4 | CID000001222 | |
| Drug | E2-3,4-Q | 1.07e-04 | 32 | 177 | 4 | CID000067402 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 1.12e-04 | 61 | 177 | 5 | CID000003868 | |
| Drug | mebendazole | 1.21e-04 | 33 | 177 | 4 | CID000004030 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.21e-04 | 33 | 177 | 4 | CID000002071 | |
| Drug | Mspg | 1.25e-04 | 13 | 177 | 3 | CID003964410 | |
| Drug | MSOPPE | 1.25e-04 | 13 | 177 | 3 | CID005311463 | |
| Drug | AC1NSKBB | 1.25e-04 | 13 | 177 | 3 | CID005311256 | |
| Drug | CPPG | 1.36e-04 | 34 | 177 | 4 | CID000002878 | |
| Drug | NSC376450 | 1.36e-04 | 34 | 177 | 4 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.36e-04 | 34 | 177 | 4 | CID000161091 | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.44e-04 | 194 | 177 | 8 | 3679_UP | |
| Drug | 1m5d | 1.53e-04 | 35 | 177 | 4 | CID000447082 | |
| Drug | MTPG | 1.58e-04 | 14 | 177 | 3 | CID005311456 | |
| Drug | 2-methyl-6-styrylpyridine | 1.58e-04 | 14 | 177 | 3 | CID000235382 | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2974_UP | |
| Drug | Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 3125_DN | |
| Drug | R,S)-AMPA | 1.71e-04 | 36 | 177 | 4 | CID000001221 | |
| Drug | AC1L3NGJ | 1.71e-04 | 36 | 177 | 4 | CID000092121 | |
| Drug | dichlobanil | 1.79e-04 | 3 | 177 | 2 | ctd:C055869 | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 1.79e-04 | 3 | 177 | 2 | ctd:C523415 | |
| Drug | melatonin | CYP2A6 CYP2A7 CYP2A13 GRIK3 GRINA GRM4 GRM5 GRM6 LDLR TLR3 TAF4 DNAJB2 | 1.90e-04 | 443 | 177 | 12 | CID000000896 |
| Drug | cellobiitol | 1.91e-04 | 37 | 177 | 4 | CID000003871 | |
| Drug | NCGC00185761-01 | 1.96e-04 | 15 | 177 | 3 | CID006426925 | |
| Drug | 4CPG | 2.12e-04 | 38 | 177 | 4 | CID000005115 | |
| Drug | colchiceine | 2.12e-04 | 38 | 177 | 4 | CID000010156 | |
| Drug | felbamate | 2.16e-04 | 70 | 177 | 5 | CID000003331 | |
| Drug | ifenprodil | 2.31e-04 | 71 | 177 | 5 | CID000003689 | |
| Drug | 1-aminocyclopentane-1,3-dicarboxylate | 2.34e-04 | 111 | 177 | 6 | CID000001310 | |
| Drug | HA-966 | 2.35e-04 | 39 | 177 | 4 | CID000001232 | |
| Drug | ethylglutamate | 2.40e-04 | 16 | 177 | 3 | CID000014241 | |
| Drug | 2-PMPA | 2.40e-04 | 16 | 177 | 3 | CID010130754 | |
| Drug | norbiotin | 2.46e-04 | 72 | 177 | 5 | CID000446903 | |
| Disease | microlissencephaly (implicated_via_orthology) | 7.66e-08 | 8 | 172 | 4 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 7.66e-08 | 8 | 172 | 4 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 7.66e-08 | 8 | 172 | 4 | DOID:0080918 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.04e-06 | 64 | 172 | 6 | DOID:4947 (is_marker_for) | |
| Disease | depressive symptom measurement | TOPAZ1 TSNARE1 SPPL3 GLIS3 GRIK3 GRM5 NEGR1 ASXL3 SYNE2 PKHD1 KMT2A SDK1 | 8.32e-06 | 426 | 172 | 12 | EFO_0007006 |
| Disease | lissencephaly (implicated_via_orthology) | 1.76e-05 | 27 | 172 | 4 | DOID:0050453 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.90e-05 | 61 | 172 | 5 | DOID:3587 (is_marker_for) | |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 3.38e-05 | 2 | 172 | 2 | EFO_0021111 | |
| Disease | unipolar depression, bipolar disorder | 3.80e-05 | 156 | 172 | 7 | EFO_0003761, MONDO_0004985 | |
| Disease | nicotine metabolite ratio | 4.12e-05 | 12 | 172 | 3 | EFO_0007794 | |
| Disease | Colorectal Carcinoma | EPHB6 CYP2A6 VPS18 LAMA1 GRIK3 WNK1 CDC14A LRRC47 ARAP3 NPAP1 PKHD1 PAN2 MTDH IL6ST | 6.84e-05 | 702 | 172 | 14 | C0009402 |
| Disease | unipolar depression | CASP8AP2 ITGA11 KCNH8 CCDC73 SPPL3 RNF213 MUC5B GRIK3 GRM5 LDLR MANSC1 ARAP3 NEGR1 ASXL3 VCAN SYNE2 PKHD1 PCDH1 SDK1 | 8.44e-05 | 1206 | 172 | 19 | EFO_0003761 |
| Disease | Myeloid Leukemia | 1.49e-04 | 18 | 172 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.49e-04 | 18 | 172 | 3 | C0023466 | |
| Disease | Hepatic fibrosis | 1.92e-04 | 49 | 172 | 4 | HP_0001395 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 2.01e-04 | 4 | 172 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 2.01e-04 | 4 | 172 | 2 | cv:C5574675 | |
| Disease | Nicotine dependence | 2.01e-04 | 4 | 172 | 2 | cv:C0028043 | |
| Disease | Gilles de la Tourette syndrome (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:11119 (implicated_via_orthology) | |
| Disease | Tobacco addiction, susceptibility to | 2.01e-04 | 4 | 172 | 2 | cv:C1861063 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 2.01e-04 | 4 | 172 | 2 | cv:C2752089 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 2.01e-04 | 4 | 172 | 2 | 201300 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 2.01e-04 | 4 | 172 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO | 2.01e-04 | 4 | 172 | 2 | 188890 | |
| Disease | insomnia measurement | 2.90e-04 | 443 | 172 | 10 | EFO_0007876 | |
| Disease | sodium measurement | 3.51e-04 | 103 | 172 | 5 | EFO_0009282 | |
| Disease | response to cranial radiation therapy, short-term memory | 4.22e-04 | 60 | 172 | 4 | EFO_0004335, EFO_0010950 | |
| Disease | Carcinoma, Granular Cell | 6.04e-04 | 116 | 172 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.04e-04 | 116 | 172 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.04e-04 | 116 | 172 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.04e-04 | 116 | 172 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.04e-04 | 116 | 172 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 6.04e-04 | 116 | 172 | 5 | C0001418 | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 6.96e-04 | 7 | 172 | 2 | cv:C0349788 | |
| Disease | retinal detachment | 6.96e-04 | 7 | 172 | 2 | EFO_0005773 | |
| Disease | Cornelia De Lange Syndrome | 9.24e-04 | 8 | 172 | 2 | C0270972 | |
| Disease | Nonsyndromic genetic hearing loss | 1.03e-03 | 76 | 172 | 4 | cv:C5680182 | |
| Disease | glycine measurement | 1.28e-03 | 137 | 172 | 5 | EFO_0009767 | |
| Disease | diet measurement | PIGS MFSD6 GLIS3 GRIK3 GRM5 LDLR GLCCI1 THADA NRXN3 MUC17 NEGR1 PKHD1 DEPDC5 ADGRL2 SDK1 | 1.29e-03 | 1049 | 172 | 15 | EFO_0008111 |
| Disease | Nonsyndromic Deafness | 1.31e-03 | 81 | 172 | 4 | C3711374 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.47e-03 | 10 | 172 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | otitis media (is_marker_for) | 1.47e-03 | 10 | 172 | 2 | DOID:10754 (is_marker_for) | |
| Disease | fasting blood glucose measurement | 1.53e-03 | 287 | 172 | 7 | EFO_0004465 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.72e-03 | 293 | 172 | 7 | C1708349 | |
| Disease | Ankylosing spondylitis | 1.79e-03 | 11 | 172 | 2 | C0038013 | |
| Disease | Stomach Neoplasms | 1.86e-03 | 297 | 172 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.97e-03 | 300 | 172 | 7 | C0024623 | |
| Disease | endometriosis, unipolar depression | 2.02e-03 | 43 | 172 | 3 | EFO_0001065, EFO_0003761 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 2.15e-03 | 12 | 172 | 2 | C1861063 | |
| Disease | immunoglobulin isotype switching measurement | 2.16e-03 | 44 | 172 | 3 | EFO_0010128 | |
| Disease | Squamous cell carcinoma of esophagus | 2.35e-03 | 95 | 172 | 4 | C0279626 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.53e-03 | 13 | 172 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.53e-03 | 13 | 172 | 2 | C0270914 | |
| Disease | wellbeing measurement | FAT4 TSNARE1 GLIS3 GRIK3 GRM5 SLC34A1 ASXL3 PTPRQ PKHD1 KMT2A SDK1 | 2.56e-03 | 692 | 172 | 11 | EFO_0007869 |
| Disease | neuroticism measurement | TSNARE1 GLIS3 GRIK3 GRM5 MSL2 NEGR1 ASXL3 SORCS2 PKHD1 KMT2A USP35 SDK1 EPB41L2 | 2.69e-03 | 909 | 172 | 13 | EFO_0007660 |
| Disease | serum gamma-glutamyl transferase measurement | CYP2A6 SPPL3 GLIS3 TBC1D8 MET THADA SOWAHA SLC24A2 EPHA2 PKHD1 KMT2A TAF4 ADGRL2 | 2.82e-03 | 914 | 172 | 13 | EFO_0004532 |
| Disease | neurotic disorder | 2.93e-03 | 101 | 172 | 4 | EFO_0004257 | |
| Disease | Hamman-Rich syndrome | 2.94e-03 | 14 | 172 | 2 | C0085786 | |
| Disease | high grade glioma (biomarker_via_orthology) | 3.37e-03 | 15 | 172 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 3.37e-03 | 15 | 172 | 2 | EFO_0007804, GO_0036273 | |
| Disease | response to antidepressant | 3.79e-03 | 176 | 172 | 5 | GO_0036276 | |
| Disease | Chromosome Aberrations | 3.84e-03 | 16 | 172 | 2 | C0008625 | |
| Disease | Schizoaffective disorder-bipolar type | 3.84e-03 | 16 | 172 | 2 | EFO_0009965 | |
| Disease | Autosome Abnormalities | 3.84e-03 | 16 | 172 | 2 | C0004403 | |
| Disease | smoking behavior | 3.99e-03 | 341 | 172 | 7 | EFO_0004318 | |
| Disease | parathyroid hormone measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0004752 | |
| Disease | Malignant neoplasm of breast | FLNB PIGS UBR4 MFSD9 GRIK3 GRM6 WNK1 ZDHHC4 SLC6A3 ARAP3 GUCY2F ZFP64 SYNE2 MTDH | 4.26e-03 | 1074 | 172 | 14 | C0006142 |
| Disease | Dementia | 4.34e-03 | 17 | 172 | 2 | C0497327 | |
| Disease | Moyamoya Disease | 4.34e-03 | 17 | 172 | 2 | C0026654 | |
| Disease | sphingomyelin 14:0 measurement | 4.34e-03 | 17 | 172 | 2 | EFO_0010390 | |
| Disease | coffee consumption measurement | 4.37e-03 | 182 | 172 | 5 | EFO_0006781 | |
| Disease | Malignant neoplasm of endometrium | 4.86e-03 | 18 | 172 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.86e-03 | 18 | 172 | 2 | C0346191 | |
| Disease | Usual Interstitial Pneumonia | 5.41e-03 | 19 | 172 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 5.41e-03 | 19 | 172 | 2 | C4721508 | |
| Disease | caffeine metabolite measurement | 5.41e-03 | 19 | 172 | 2 | EFO_0007872 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVLAFSLSSITSVTV | 341 | Q0P6H9 | |
| TIRETSQTSTLQSLT | 471 | Q8N1M1 | |
| TDFSRFLQSSSTTLI | 726 | Q68DN1 | |
| FLQSSSTTLISSSVR | 731 | Q68DN1 | |
| STTLISSSVRTASEL | 736 | Q68DN1 | |
| ELIQDTSTSFSTTRE | 1416 | Q8WWN8 | |
| VTDLSQRNTTDTLIT | 1656 | P13611 | |
| ATTQATRQESSTTFV | 2446 | P13611 | |
| TFFLSRTVSNVISSI | 171 | P11509 | |
| AVTKTTSLFSTIEST | 396 | Q8IZF6 | |
| TVRSFSINSRLASSL | 471 | Q9UNH5 | |
| YIQTTTLTVSVSLSA | 816 | Q14833 | |
| RLLSTLFNTTTISQV | 96 | P0C5Y9 | |
| RLLSTLFNTTTISQV | 96 | P0C5Z0 | |
| FIVESNSSSSTRSAV | 96 | P48507 | |
| LSSSTSVLVTVTDVN | 2446 | Q6V0I7 | |
| AELFKTIISTTSTTS | 411 | O95490 | |
| TLTVEQLSSRVSFTS | 491 | Q86VQ1 | |
| TSLVSSRSFQTSAIS | 51 | Q06055 | |
| RAVSLVTDSTSTFLS | 76 | Q9NR28 | |
| KTFTVSSSVTFQVTR | 186 | Q8N126 | |
| SSSATEVVLRTRTAS | 381 | Q9UBW5 | |
| ALSTTVSETTESILQ | 751 | Q9UKL3 | |
| TTNTILLSSEKRSFT | 81 | Q02487 | |
| IRSLLTVETFSVSSS | 1256 | Q96BY7 | |
| LTSSLSLTVSVESSE | 1481 | Q9C0F0 | |
| LETATTTTTQALFST | 1616 | Q9HC84 | |
| ILTELTTAATTTAAT | 4391 | Q9HC84 | |
| TRILTELTTTATTTA | 4816 | Q9HC84 | |
| FSVSTVSSSVLTTLR | 4916 | Q9HC84 | |
| NSVSQLISRSTDSTL | 501 | Q9HBD1 | |
| TTTSNLLLESEQSTS | 186 | O60216 | |
| FLVVSVTLTSVSTEN | 641 | Q4ADV7 | |
| EFRTTTVNIGSISTA | 31 | Q96B26 | |
| ITSSVVASRTRFFET | 771 | O60890 | |
| SSVTTAFFSVITSIL | 551 | Q9HCM3 | |
| FSFSSTITSDITNVS | 1396 | Q7Z5J8 | |
| TATSITASIISFIII | 506 | Q4KMQ2 | |
| SVSTLNSEDFVLVSR | 16 | Q9Y3P9 | |
| LVASSLTSSSTLTEI | 1166 | O75140 | |
| AITTTVSSTLTRAVT | 1471 | P51610 | |
| VSSTLTRAVTTVTQS | 1476 | P51610 | |
| LVSELRATSSTSVTN | 916 | Q8WXI7 | |
| EVTSSSSVLRTLNTL | 3896 | Q8WXI7 | |
| KLRETSISQEITSST | 4896 | Q8WXI7 | |
| STVSLDISTETNTRL | 4946 | Q8WXI7 | |
| ITQASRTEISSSRTS | 5516 | Q8WXI7 | |
| AFFETRIQTESTSSL | 5766 | Q8WXI7 | |
| TTEVSRTEVITSSRT | 5811 | Q8WXI7 | |
| TFSLIFRLRETSTSQ | 6361 | Q8WXI7 | |
| FTAATTEVSRTELTS | 6391 | Q8WXI7 | |
| LSSTSVEILATSEVT | 7451 | Q8WXI7 | |
| TTEVSRTEAISFSRT | 7571 | Q8WXI7 | |
| FETSRIQTEPTSSLT | 8106 | Q8WXI7 | |
| LTSGLREISTSQETS | 8706 | Q8WXI7 | |
| RETRTSQDITSSTET | 9586 | Q8WXI7 | |
| SRAVTSTTIPILTFS | 10941 | Q8WXI7 | |
| TISLASQATDTFSTV | 921 | Q99102 | |
| SETVRASSTLLFTLS | 671 | Q504Q3 | |
| ISSVVTRFTANISEL | 1061 | P41594 | |
| LQLSVTLSTVSVFTF | 171 | Q7Z429 | |
| LVTLTASATVSISDL | 581 | Q6DN14 | |
| TNSEEVRLRSFTTTI | 176 | Q13257 | |
| QQTASSSSTLVEVTL | 36 | P43356 | |
| KIQTLTSSVRESSFV | 56 | P16435 | |
| FSTRSILTVTNVTQE | 276 | Q7Z3B1 | |
| VSTALSGFTIFRTIS | 431 | Q9BQ67 | |
| LTSTADATISTTVLI | 2106 | Q2M2H8 | |
| TITESSSLLLSQLTS | 821 | Q8N201 | |
| AVVLSSTLLSFSTAI | 376 | Q8NBP5 | |
| TSDLFLEVTSATSLQ | 476 | Q8N1G4 | |
| DISVSAQTLSISRSV | 676 | P56696 | |
| SEETTTSSSRIFVKI | 571 | Q9HCG8 | |
| TTLVNSIVLEFTTSE | 4986 | Q5CZC0 | |
| TLLTAQTITSESVST | 921 | O43491 | |
| STSAISEIQSSLTSI | 826 | Q9P2D6 | |
| TVSFTNEVFTTETSR | 231 | Q9HCN6 | |
| NEVFTTETSRSITAS | 236 | Q9HCN6 | |
| SSILVESVTRSSTET | 2486 | O75369 | |
| FSVLSTALQSRSTNI | 536 | Q9HCI6 | |
| TILSSLSFDREQQST | 666 | Q08174 | |
| FLTTATDLTSTFTVS | 461 | Q02505 | |
| STLVTTLLTTITRST | 1066 | Q02505 | |
| RITENTPISSFSTSI | 2556 | Q02505 | |
| QTAVITRIASSQTTI | 421 | Q9H4H8 | |
| TLISTVFTRAAATLQ | 281 | Q9H8J5 | |
| LLRSTTSTIESFAAQ | 171 | O95232 | |
| ISLQTTFSLASNVTL | 1126 | Q9ULI3 | |
| TLSFDTTVFIIESTR | 821 | Q9UKX5 | |
| LNASLQETSVSISST | 1081 | P23471 | |
| KRQSVTTSFLSILTT | 486 | Q6ZWE6 | |
| TTSFLSILTTLSLER | 491 | Q6ZWE6 | |
| FSASSVTIVDTVTLQ | 301 | Q6ZSS7 | |
| VTQEFVSRTLTTSGT | 1796 | P16144 | |
| VTSIAVRNASTSTSV | 531 | Q9HCI7 | |
| NQVSSLLSVRTSETV | 786 | Q9UMZ3 | |
| LDTVSIISNISQSST | 631 | Q86SP6 | |
| VTVLVQSSSTSTSII | 156 | Q06495 | |
| QSVSISVSIFSLVFT | 116 | Q99463 | |
| FLSLVSRVDSISSSL | 116 | Q5VYJ5 | |
| IETSFSSSSTLVALS | 626 | Q9Y2F5 | |
| IINRTASSVTFTDIA | 81 | P40189 | |
| FSLQNTVTTGIVSTT | 286 | Q92743 | |
| QTTTLTVSLSLSASV | 816 | O15303 | |
| SSLITDLQTITRDSQ | 1956 | Q4AC94 | |
| TFFLSRTVSNVISSI | 171 | Q16696 | |
| TLSASTTETLLSELV | 71 | Q99715 | |
| VTVSREATTLTIVFS | 61 | O95273 | |
| TSLVLSQVTSSSIRL | 381 | Q9P218 | |
| SVSTSTTFVQGRRIT | 166 | P25686 | |
| TFFLSRTVSNVISSI | 171 | P20853 | |
| LVTSRSFRTASVSIN | 421 | P29317 | |
| DSITVTFTSLNETVT | 491 | Q8ND61 | |
| TFTSLNETVTLTVSA | 496 | Q8ND61 | |
| ISSVRNLTIRSSSFS | 2596 | P15924 | |
| LISRESLASTTLSLT | 46 | Q8NEA6 | |
| SRASVSFQITSEVQS | 526 | P51841 | |
| STFTLQSSSETLFSI | 11 | Q6ZRK6 | |
| AFSLSSTALVSVRVT | 2901 | Q8TDW7 | |
| SQGTTTFAVTSILRV | 286 | P01876 | |
| TVTDITANSITVTFR | 221 | O95931 | |
| TDSQVSETTTRISLL | 366 | Q9NSG2 | |
| QSFSPSVITRTTEIT | 51 | Q5U623 | |
| FTSQESETSLQSIRL | 1091 | Q99698 | |
| NSLEVLRVTAFSTSE | 836 | Q6ZN28 | |
| DLFSTFTITRLQETT | 941 | O00754 | |
| NTITVTTEQLTTASF | 226 | Q86UE4 | |
| LLVSESSQRTDLSTT | 3196 | Q03164 | |
| LTAFATLASTSSTQL | 371 | Q9ULL0 | |
| FESSSSTLTFQIVTD | 116 | Q86UP6 | |
| IITFSASSTSEVITR | 341 | Q86UP6 | |
| VTSIIRSSQTSLVTC | 86 | Q8NBF1 | |
| NVTDSLTNRSLIVTT | 426 | Q13003 | |
| SSDVTTIRTSVTFKL | 481 | Q9NQ36 | |
| SFLAFSEITSTTLNV | 1806 | Q7Z5N4 | |
| AATVRLLSSSQIITS | 6 | P54277 | |
| LLSSSQIITSVVSVV | 11 | P54277 | |
| TVLRTFRSLSTTNVF | 636 | Q16531 | |
| AAVTSTSLTIKSVFT | 186 | P20273 | |
| TFRVTVLQASSISAE | 1001 | Q12756 | |
| TTVASSEINTLSTTL | 1936 | Q685J3 | |
| SEINTLSTTLADTRT | 1941 | Q685J3 | |
| SLQTSLTSTSEFTTE | 561 | Q9H195 | |
| STSTNAILTSFSTII | 581 | Q9H195 | |
| SVENLATATTTLTSL | 431 | Q96S52 | |
| RGLFSVLSTSQSLTE | 731 | Q96P20 | |
| TVLSDFISRSSAFIS | 631 | Q2WGJ9 | |
| STINLSLSTRVTLAF | 6 | Q9H3N8 | |
| SELVSRISAIFSTFI | 1331 | P08581 | |
| NFTRFSSLIVLTSTV | 171 | Q9NYV8 | |
| TALTAVVLSSSVQRT | 691 | O00268 | |
| VSSVFREITASSAIS | 61 | Q8IUI4 | |
| TESRLAVVEVLTSTT | 1696 | Q6YHU6 | |
| NVESTRTFLQTVSSE | 26 | Q96EL3 | |
| TSVSFISTVATIRAS | 546 | Q8IYR2 | |
| TATFLVSLTSSSVAD | 296 | Q14DG7 | |
| VSLTSSSVADQFTLR | 301 | Q14DG7 | |
| TTSVENLFRFLTDTS | 5706 | Q8WXH0 | |
| LVAISTVSFSISAFS | 46 | Q9UI40 | |
| TTTTSLSPELIRFTA | 466 | Q9HDB5 | |
| TVTETSLLSESLVSN | 1926 | P25391 | |
| FTLTSETNTATVTQL | 536 | O15197 | |
| STRQALSTATATVSV | 486 | P58107 | |
| VASRAQVSLISTSFV | 126 | Q96PQ0 | |
| ISTDTEFLSIITSSQ | 236 | Q86V20 | |
| QLASVTRISSSDLSL | 381 | Q9UHJ6 | |
| LLTLDDVSSSSVTVS | 76 | Q13203 | |
| ASSALVFTSRVIITA | 1726 | P08F94 | |
| ASTLETTFETISTLS | 341 | Q9NSE4 | |
| QVSSNSTSRVFTTLV | 861 | Q15477 | |
| ALLVTLSFSSISTSS | 1041 | Q96J65 | |
| VVIFTSSLSSRVSSL | 586 | Q9NZP6 | |
| TLSFQTLRTTVKEAS | 331 | P27930 | |
| ETLTITVTSRAANSS | 576 | Q14CN2 | |
| TLATLATRAQTVATT | 206 | Q96F05 | |
| VLVTVLVQSSSTSTS | 151 | O95436 | |
| LNDTVTVRLSTSSNS | 1191 | Q63HN8 | |
| RATLQIFSTGSITVT | 146 | P62380 | |
| LSNSFTSLRTLTNET | 386 | O15455 | |
| TSLRTLTNETFVSLA | 391 | O15455 | |
| TSSRLFSEIQTTLGT | 856 | Q12768 | |
| INSSVTSLERSLQSL | 271 | Q96NA8 | |
| RSQISTITVATFNTT | 566 | Q8N2C7 | |
| RSSSNTKAVTTFTIT | 286 | P04198 | |
| QVAATILSSTTSAFL | 466 | Q2M3V2 | |
| SSTVFLLALTIIAST | 6 | P04844 | |
| SLVDSSQVSTFLISI | 11 | Q8TCT6 | |
| RSTVSKSILDQSISS | 241 | O00338 | |
| TSNVFLTDTIRITTQ | 211 | O95759 | |
| TRVSFSSFESVSNVT | 896 | Q9P2H5 | |
| LTASAATVAIVSTTF | 201 | Q9NPG8 | |
| FTPSERITSLVVSSN | 51 | Q9P253 | |
| AIVTTSINSLTSFSS | 346 | Q01959 | |
| SSLVSVRSKQISSSL | 1171 | O94964 | |
| VTVFISSSLNTFRSE | 11 | Q99426 | |
| IETASSQRDTVLSTL | 1996 | Q6ZS81 | |
| ATQSILILVSTFVSS | 231 | Q7Z5H5 | |
| LSQLSVTDVTTSSLR | 146 | Q16473 | |
| VFTASSSNSELIRIA | 1071 | Q96JH7 | |
| LVRKESLTSSESFQT | 136 | Q8N9V7 | |
| TTTSSSLFIDSLTTE | 381 | Q8IUK5 | |
| TVSTINTITRETSSL | 211 | Q9C0D7 | |
| SSVFTESRVSSQQTV | 661 | Q9H4A3 | |
| LSTVASSINALATVT | 346 | Q1EHB4 | |
| ISQIVSSITASLRFD | 231 | P68363 | |
| LDSQFASIETITTTI | 421 | Q9UN76 | |
| SFAATISRTTLEVLQ | 2131 | Q5T4S7 | |
| TITTRTSSQVTFPID | 2276 | Q5T4S7 | |
| QTTTRTITSETQTIT | 81 | Q9NTW7 | |
| ISQIVSSITASLRFD | 231 | Q9BQE3 | |
| ISQIVSSITASLRFD | 231 | Q9NY65 | |
| ISQIVSSITASLRFD | 231 | P68366 | |
| LSTTRSTTVSDIAVE | 251 | Q96L42 | |
| TQETSTVRLKVSSTA | 721 | P01130 | |
| TSSVFQEVTLRLTVS | 166 | Q9BTE0 |